Skip to main content
Cornell University
We gratefully acknowledge support from the Simons Foundation, member institutions, and all contributors. Donate
arxiv logo > q-bio > arXiv:2001.10573

Help | Advanced Search

arXiv logo
Cornell University Logo

quick links

  • Login
  • Help Pages
  • About

Quantitative Biology > Populations and Evolution

arXiv:2001.10573 (q-bio)
[Submitted on 28 Jan 2020]

Title:Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer

Authors:Heyrim Cho, Zuping Wang, Doron Levy
View a PDF of the paper titled Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer, by Heyrim Cho and Zuping Wang and Doron Levy
View PDF
Abstract:Adoptive T cell based immunotherapy is gaining significant traction in cancer treatment. Despite its limited success, so far, in treating solid cancers, it is increasingly successful, demonstrating to have a broader therapeutic potential. In this paper we develop a mathematical model to study the efficacy of engineered T cell receptor (TCR) T cell therapy targeting the E7 antigen in cervical cancer cell lines. We consider a dynamical system that follows the population of cancer cells, TCR T cells, and IL-2. We demonstrate that there exists a TCR T cell dosage window for a successful cancer elimination that can be expressed in terms of the initial tumor size. We obtain the TCR T cell dose for two cervical cancer cell lines: 4050 and CaSki. Finally, a combination therapy of TCR T cell and IL-2 treatment is studied. We show that certain treatment protocols can improve therapy responses in the 4050 cell line, but not in the CaSki cell line.
Comments: 8 pages, 7 figures
Subjects: Populations and Evolution (q-bio.PE); Tissues and Organs (q-bio.TO)
MSC classes: 92B05
Cite as: arXiv:2001.10573 [q-bio.PE]
  (or arXiv:2001.10573v1 [q-bio.PE] for this version)
  https://doi.org/10.48550/arXiv.2001.10573
arXiv-issued DOI via DataCite
Related DOI: https://doi.org/10.1016/j.jtbi.2020.110403
DOI(s) linking to related resources

Submission history

From: Heyrim Cho [view email]
[v1] Tue, 28 Jan 2020 20:13:17 UTC (912 KB)
Full-text links:

Access Paper:

    View a PDF of the paper titled Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer, by Heyrim Cho and Zuping Wang and Doron Levy
  • View PDF
  • TeX Source
  • Other Formats
view license
Current browse context:
q-bio.PE
< prev   |   next >
new | recent | 2020-01
Change to browse by:
q-bio
q-bio.TO

References & Citations

  • NASA ADS
  • Google Scholar
  • Semantic Scholar
a export BibTeX citation Loading...

BibTeX formatted citation

×
Data provided by:

Bookmark

BibSonomy logo Reddit logo

Bibliographic and Citation Tools

Bibliographic Explorer (What is the Explorer?)
Connected Papers (What is Connected Papers?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)

Code, Data and Media Associated with this Article

alphaXiv (What is alphaXiv?)
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Hugging Face (What is Huggingface?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)

Demos

Replicate (What is Replicate?)
Hugging Face Spaces (What is Spaces?)
TXYZ.AI (What is TXYZ.AI?)

Recommenders and Search Tools

Influence Flower (What are Influence Flowers?)
CORE Recommender (What is CORE?)
  • Author
  • Venue
  • Institution
  • Topic

arXivLabs: experimental projects with community collaborators

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.

Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.

Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

Which authors of this paper are endorsers? | Disable MathJax (What is MathJax?)
  • About
  • Help
  • contact arXivClick here to contact arXiv Contact
  • subscribe to arXiv mailingsClick here to subscribe Subscribe
  • Copyright
  • Privacy Policy
  • Web Accessibility Assistance
  • arXiv Operational Status
    Get status notifications via email or slack